In the latest edition of Executive Insights, we spotlight Areo Nazari, Co-Founder & CEO of CaryHealth, a Washington, DC–based digital health company redefining the future of healthcare. CaryHealth is creating AI-powered tools that make healthcare more personal, more proactive, and more efficient—for patients and providers alike.
From its roots as a direct-to-consumer digital pharmacy, CaryHealth has grown into a comprehensive health intelligence platform. Its suite of products—including CaryRx, OneDash, Clair, and CaryConnect—now supports everything from medication fulfillment to real-time clinical decision-making. In the interview, Areo shares how their work is helping patients stay on track with treatment plans while giving care teams the data they need to intervene early and effectively.
Based in the District since its founding in 2017, CaryHealth has leveraged DC’s unique combination access to top-tier talent and a thriving ecosystem of health and technology innovators.
In 2025, Inc. named CaryHealth the #1 fastest-growing private company in the Mid-Atlantic region, citing over 3,000% revenue growth in just two years The company also ranked in the Top 100 on the 2024 Inc. 5000 national list and was previously recognized as the #2 AI company in healthcare and the #1 fastest-growing company in DC.
The CaryHealth story is a window into what’s possible in the District’s growing life sciences and digital health sectors. CaryHealth exemplifies how innovative startups can scale with impact by tapping into Washington, DC’s policy capital, research institutions, and civic-minded business community.
